mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
-0.02 |
0.9 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |